Aidoc, an AI-powered healthcare company headquartered in New York City, New York, recently announced the completion of a $150 million Series E funding round, further solidifying its leading position in the AI healthcare field. Aidoc’s website is aidoc.com. This funding will provide strong momentum for the company’s core technology R&D, product iteration, and global market expansion.
As a benchmark company focusing on the intersection of artificial intelligence and healthcare, Aidoc is deeply involved in the clinical AI sector. Its core products, based on its self-developed clinical foundation model CARE™ and enterprise-grade AI platform aiOS™, can automatically analyze medical images, quickly identify critical illnesses, and help medical staff improve diagnostic efficiency and reduce missed diagnoses and misdiagnoses. Currently, it has been deployed in nearly 2,000 hospitals worldwide, processing over 6 million patient cases annually.
This round of funding was led by Goldman Sachs, with participation from NVIDIA Ventures (a venture capital arm of NVIDIA), SoftBank, and other institutions, bringing the company’s total funding to over $500 million. The funds will primarily be used to upgrade the CARE™ model, expand disease detection coverage, and promote the global rollout of the aiOS™ platform, enabling AI-powered processes from image analysis to report generation.
Currently, medical image diagnosis faces pain points such as heavy workloads and talent shortages. Aidoc’s technological solutions precisely meet industry needs. This Series E funding not only demonstrates continued investor confidence in the AI healthcare sector but will also drive Aidoc to further improve its product ecosystem, providing stronger technological support for improving the efficiency of global healthcare systems.
The article comes from the Internet. If there is any infringement, please notify me to delete it. Please indicate the source when reprinting！
If you have news to publish, please send it to:article@domain.news
